BioShares Biotechnology Clinical Trials ETF (BBC) ETF

Expense Ratio: 0.79% | AUM: 43.80M | Issuer: BioShares

BBC Daily Price Range
BBC 52-Week Price Range

BBC - Real-Time SMART Grade™

A
Strong Buy

Overall SMART Grade

BBC has a real-time SMART Grade of A (Strong Buy).

Learn More About SMART Grades™

BBC - Profile & Info


The investment objective of the Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. The clinical trials index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development.

Issuer BioShares
Expense Ratio 0.79%
Assets Under Management (AUM) 43.80M
Underlying Index BioShares Biotechnology Clinical Trials Index
Asset Class Portfolio-Multi Asset
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $43.80
Options? Yes
Total Holdings 166

BBC - Top Holdings

Symbol Holding Name % of Total
AMRS Amyris Inc 1.69%
BNY MELLON CASH RESERVE USD 1.41%
PRVL Prevail Therapeutics Inc 1.09%
HARP Harpoon Therapeutics Inc 0.92%
HGEN Humanigen Inc 0.90%
NTLA Intellia Therapeutics Inc 0.86%
ADAP Adaptimmune Therapeutics Plc 0.85%
IMAB I-Mab 0.83%
ORTX Orchard Therapeutics PLC 0.83%
ARVN Arvinas Holding 0.82%
NK NantKwest Inc 0.81%
ODT Odonate Therapeutics Inc 0.78%
MGTX MeiraGTx Holdings PLC 0.76%
CRSP CRISPR Therapeutics AG 0.75%
XENE Xenon Pharmaceuticals Inc 0.74%
DTIL Precision BioSciences Inc 0.73%
EDIT EDITAS MEDICIN 0.72%
KOD Kodiak Sciences Inc 0.71%
RGNX Regenxbio Inc 0.71%
TCRR TCR2 Therapeutics Inc 0.71%
SGMO Sangamo Therapeutics Inc 0.71%
TGTX TG Therapeutics Inc 0.71%
CDXS Codexis Inc 0.70%
BLUE BLUEBIRD BIO INC 0.69%
RLMD Relmada Therapeutics Inc 0.69%
FATE FATE THERAPEUTIC 0.68%
STRO Sutro Biopharma Inc 0.68%
CARA Cara Therapeutics Inc 0.68%
KRTX Karuna Therapeutics Inc 0.68%
KRYS Krystal Biotech Inc 0.67%
BTAI BioXcel Therapeutics Inc 0.67%
IMTX Immatics NV 0.67%
COGT Cogent Biosciences Inc 0.66%
BBIO BridgeBio Pharma Inc 0.66%
AVRO Avrobio Inc 0.66%
EIDX Eidos Therapeutics Inc 0.66%
SRRK Scholar Rock Holding Corp 0.65%
ARWR Arrowhead Pharmaceutical 0.65%
ARNA Arena Pharmaceuticals 0.65%
RIGL Rigel Pharmaceuticals Inc 0.65%
ITOS ITEOS THERAPEUTICS INC 0.64%
SELB Selecta Biosciences Inc 0.64%
VSTM Verastem Inc 0.64%
ALXO ALX ONCOLOGY HOLDINGS 0.63%
RYTM Rhythm Pharmaceuticals Inc 0.63%
MCRB Seres Therapeutics Inc 0.63%
RETA Reata Pharmaceuticals Inc 0.63%
ALLK Allakos Inc 0.63%
RPTX Repare Therapeutics Inc 0.62%
CRNX Crinetics Pharmaceuticals Inc 0.62%
PRTA Prothena Corp PLC 0.62%
APLS Apellis Pharmaceuticals 0.62%
RCUS ARCUS BIOSCIEN 0.62%
XNCR Xencor Inc 0.62%
FIXX Homology Medicines Inc 0.62%
RUBY Rubius Therapeutics Inc 0.62%
ZYME ZYMEWORKS INC 0.62%
PRVB Provention Bio Inc 0.62%
STOK Stoke Therapeutics Inc 0.61%
IGMS IGM Biosciences Inc 0.61%
ALVR ALLOVIR INC 0.61%
ARDX Ardelyx Inc 0.61%
ALEC Alector 0.61%
VYGR Voyager Therapeutics Inc 0.61%
AMTI APPLIED MOLECULAR TRANSPORT INC 0.61%
MTEM Molecular Templates Inc 0.60%
GTHX G1 Therapeutics Inc 0.60%
VKTX Viking Therapeutics Inc 0.60%
PTGX Protagonist Therapeutics Inc 0.60%
WVE WAVE Life Sciences Ltd 0.59%
PLRX PLIANT THERAPEUTICS INC 0.59%
ANAB Anaptys Bio Inc 0.59%
ZIOP ZIOPHARM Oncology Inc 0.59%
TPTX Turning Point Therapeutics Inc 0.59%
ALLO Allogene Therapeutics 0.59%
AXSM AXME THERAPUTI 0.59%
CRTX Cortexyme Inc 0.59%
KZR Kezar Life Sciences Inc 0.59%
GOSS Gossamer Bio Inc 0.59%
UROV Urovant Sciences Ltd 0.59%
DVAX DYNAVAX TECHNO 0.59%
SYRS Syros Pharmaceuticals Inc 0.59%
SRNE Sorrento Therapeutics Inc 0.58%
NXTC NextCure Inc 0.58%
AKRO Akero Therapeutics Inc 0.58%
RCKT Rocket Pharmaceuticals Inc 0.58%
CGEN Compugen Ltd 0.58%
MEIP MEI Pharma Inc 0.58%
CLDX Celldex Therapeutics Inc 0.58%
IOVA Iovance Biotherapeutics Inc 0.58%
TCDA Tricida Inc 0.58%
VIR Vir Biotechnology Inc 0.58%
REPL Replimune Group Inc 0.57%
APLT Applied Therapeutics Inc 0.57%
FREQ FREQUENCY THERAPEUTICS 0.57%
DRNA DICERNA PHARMA 0.57%
NGM NGM Biopharmaceuticals Inc 0.57%
LEGN Legend Biotech Corp 0.57%
CCXI ChemoCentryx Inc 0.57%
KNSA Kiniksa Pharmaceuticals Ltd 0.57%
CTMX CytomX Therapeutics Inc 0.57%
IMGN IMMUNOGEN INC 0.57%
IMVT Immunovant Inc 0.56%
AKBA Akebia Therapeutics Inc 0.56%
NVAX Novavax Inc 0.56%
ZNTL Zentalis Pharmaceuticals Inc 0.56%
CVM CEL-SCI Corp 0.56%
ASND Ascendis Pharma A/S 0.56%
BCRX BioCryst Pharmaceuticals Inc 0.56%
GMDA Gamida Cell Ltd 0.56%
DNLI Denali Therapeutics Inc 0.56%
GERN Geron Corp 0.55%
AFMD Affimed NV 0.55%
OYST Oyster Point Pharma Inc 0.55%
PGEN Precigen Inc 0.55%
ARQT ARCUTIS BIOTHERAPEUTICS 0.55%
SNDX Syndax Pharmaceuticals Inc 0.55%
FPRX Five Prime Therapeutics Inc 0.55%
CUE Cue Biopharma Inc 0.55%
MDGL Madrigal Pharmaceuticals Inc 0.55%
CYTK Cytokinetics Inc 0.55%
MRNS Marinus Pharmaceuticals Inc 0.55%
ISEE Iveric Bio Inc 0.54%
MYOV Myovant Sciences Ltd 0.54%
RLAY RELAY THERAPEUTICS INC 0.54%
ATNX Athenex 0.54%
KROS Keros Therapeutics Inc 0.54%
ADCT ADC Therapeutics SA 0.53%
ANNX ANNEXON INC 0.53%
ALBO ALBIREO PHARMA 0.53%
CNST Constellation Pharmaceuticals Inc 0.53%
FGEN FibroGen Inc. 0.53%
XBIT XBiotech Inc 0.53%
MORF Morphic Holding Inc 0.53%
SWTX Springworks Therapeutics Inc 0.53%
BCEL Atreca Inc 0.53%
ORIC Oric Pharmaceuticals Inc 0.52%
AGEN Agenus Inc 0.52%
RAPT RAPT Therapeutics Inc 0.52%
KDMN Kadmon Holdings Inc 0.52%
MRTX Mirati Therapeutics Inc 0.52%
CRDF Cardiff Oncology Inc 0.51%
INO Inovio Pharmaceuticals Inc 0.51%
KURA Kura Oncology Inc 0.51%
BDTX BLACK DIAMOND THERAPEUTI 0.51%
VXRT Vaxart Inc 0.51%
RVMD REVOLUTION Medicines Inc 0.51%
MGNX MacroGenics Inc 0.50%
MIRM Mirum Pharmaceuticals Inc 0.50%
ATRA Atara Biotherapeutics 0.50%
CVAC CureVac NV 0.49%
ADVM ADVERUM BIOT O 0.49%
RNA AVIDITY BIOSCIENCES INC 0.49%
ETNB 89BIO 0.49%
INBX Inhibrx Inc 0.49%
QURE uniQure NV 0.49%
TBIO Translate Bio Inc 0.49%
PHAT Phathom Pharmaceuticals Inc 0.48%
NKTX NKARTA INC 0.46%
FMTX FORMA THERAPEUTICS HOLDINGS INC 0.45%
MRSN Mersana Therapeutics Inc 0.42%
CALA Calithera Biosciences Inc 0.36%
ARCT Arcturus Therapeutics Holdings Inc 0.34%
APRE Aprea Therapeutics Inc 0.11%
Cash/Cash equivalents 0.02%
BBC Virtus LifeSci Biotech Clinical Trials ETF 0.00%

BBC - Top Stories


View All BBC News

BBC - Price/Volume Stats

Current price $54.08
Prev. close $52.12
Day low $52.38
Day high $54.29
52-week high $54.37
52-week low $23.00
Day Volume 8,200
Avg. volume 8,078
Dividend yield 0.00%

BBC - Recent Returns

1-mo 5.43%
3-mo 26.01%
6-mo 24.49%
1-year 41.34%
3-year 81.17%
5-year 160.22%
YTD 9.05%
2020 30.32%
2019 63.81%
2018 -18.29%
2017 56.12%
2016 -36.63%

BBC - Stock Chart


BBC - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...

Free Investing Ideas Newsletter!

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

Most Popular Articles



5 WINNING Stock Chart Patterns
Page generated in 1.7312 seconds.